Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun;66(6):748-50.

Interrelationship of serum S100B and P53 in brain tumour patients

Talat Syeda  1 , Husan Afroz Rizvi  1 , Syed Murtaza Hadi  2 , Abdul Sattar M Hashim  3 , Mashal Hasan Khan  4
Affiliations
  • PMID: 27339581

Interrelationship of serum S100B and P53 in brain tumour patients

Talat Syeda et al. J Pak Med Assoc. 2016 Jun.

Abstract

The interrelationship of serum S100B and P53 concentrations and their association with tumour type and size in patients was determined. S100B and P53 concentrations were measured in serum of patients and normal healthy volunteers. Serum S100B concentrations were significantly higher in patients (mean 50%) than in healthy controls (p< 0.001). P53 concentrations were elevated only in five patients (mean 28%). No significant correlation was found between S100B and P53. Significant positive correlation was observed between S100B concentration and large tumour size (p< 0.05) but not with small tumours. Similarly,there was no significant correlation between P53 concentrations and tumour size.Heterogeneity of S100B expression exists in brain tumours. However, S100B was also found to be pituitary-specific. High serum concentration of P53 was found in five patients with large tumour. These findings warrant further larger clinical studies for better understanding the interrelationship of these serum makers and the development and/or progression of these malignancies.

Keywords: S100B, P53, brain tumours, interrelationship of biomarkers..

PubMed Disclaimer